دورية أكاديمية

165P EPclin, OncotypeDx and Prosigna in lobular breast cancer (ILC): Is there an association with Ki67?

التفاصيل البيبلوغرافية
العنوان: 165P EPclin, OncotypeDx and Prosigna in lobular breast cancer (ILC): Is there an association with Ki67?
المؤلفون: Leao, I.I.L.1 (AUTHOR), Zamora, E.2 (AUTHOR), Cayuela, R.3 (AUTHOR), Villacampa Javierre, G.4 (AUTHOR), Gomez Pardo, P.2 (AUTHOR), Arumi de Dios, M.A.2 (AUTHOR), Pimentel, I.2 (AUTHOR), Escriva de Romani, S.2 (AUTHOR), Ortiz Velez, C.2 (AUTHOR), Cruellas Lapena, M.2 (AUTHOR), Sanz, L.2 (AUTHOR), Borrell Puy, M.2 (AUTHOR), De La Torre, J.5 (AUTHOR), Espinosa-bravo, M.5 (AUTHOR), Gorria, T.3 (AUTHOR), Oliveira, M.2 (AUTHOR), Saura Manich, C.2 (AUTHOR), Peg, V.6 (AUTHOR), Vidal Losada, M.J.7 (AUTHOR), Bellet Ezquerra, M.2 (AUTHOR)
المصدر: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS614-S614. 1p.
مصطلحات موضوعية: *BREAST cancer
قاعدة البيانات: Academic Search Index
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2022.07.200